Great West Life Assurance Co. Can boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 3.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 36,742 shares of the medical technology company’s stock after purchasing an additional 1,073 shares during the quarter. Great West Life Assurance Co. Can owned about 0.08% of Teleflex worth $8,833,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Toronto Dominion Bank raised its stake in shares of Teleflex by 14.5% in the second quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock valued at $115,000 after acquiring an additional 70 shares during the period. Advisory Services Network LLC raised its stake in shares of Teleflex by 933.8% in the second quarter. Advisory Services Network LLC now owns 827 shares of the medical technology company’s stock valued at $172,000 after acquiring an additional 747 shares during the period. Cornerstone Capital Management Holdings LLC. purchased a new stake in shares of Teleflex in the second quarter valued at $175,000. Calamos Advisors LLC bought a new position in shares of Teleflex in the second quarter worth about $206,000. Finally, Advisor Partners LLC bought a new position in shares of Teleflex in the second quarter worth about $212,000. 89.31% of the stock is currently owned by institutional investors and hedge funds.
A number of research firms have recently commented on TFX. Morgan Stanley upped their price target on shares of Teleflex from $274.00 to $290.00 and gave the stock an “equal weight” rating in a report on Friday, November 3rd. Leerink Swann upgraded shares of Teleflex from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $227.00 to $266.00 in a report on Thursday, September 7th. Deutsche Bank cut shares of Teleflex from a “buy” rating to a “hold” rating and set a $251.00 price target on the stock. in a report on Tuesday, November 14th. Zacks Investment Research cut shares of Teleflex from a “buy” rating to a “hold” rating in a report on Thursday, August 31st. Finally, Needham & Company LLC upped their price target on shares of Teleflex from $237.00 to $285.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company’s stock. Teleflex presently has a consensus rating of “Hold” and a consensus price target of $274.44.
In other Teleflex news, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $237.18, for a total transaction of $47,436.00. Following the transaction, the director now directly owns 8,080 shares in the company, valued at approximately $1,916,414.40. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Benson Smith sold 2,000 shares of the stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $258.10, for a total transaction of $516,200.00. Following the transaction, the chief executive officer now owns 76,634 shares in the company, valued at $19,779,235.40. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 2,600 shares of company stock worth $665,076. 2.39% of the stock is owned by company insiders.
Teleflex Incorporated (NYSE:TFX) traded down $1.23 during midday trading on Wednesday, hitting $251.75. 341,500 shares of the stock were exchanged, compared to its average volume of 260,808. The company has a current ratio of 4.72, a quick ratio of 3.70 and a debt-to-equity ratio of 0.88. Teleflex Incorporated has a 12-month low of $151.22 and a 12-month high of $271.23. The company has a market capitalization of $11,396.56, a PE ratio of 31.27, a PEG ratio of 2.16 and a beta of 1.09.
Teleflex (NYSE:TFX) last issued its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.01 by $0.11. Teleflex had a net margin of 12.41% and a return on equity of 16.27%. The company had revenue of $534.70 million for the quarter, compared to analysts’ expectations of $522.94 million. During the same period in the prior year, the business earned $1.80 EPS. The firm’s quarterly revenue was up 17.3% on a year-over-year basis. research analysts forecast that Teleflex Incorporated will post 8.35 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Wednesday, November 15th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.54%. The ex-dividend date is Tuesday, November 14th. Teleflex’s payout ratio is 24.82%.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.